Leadership
A leadership team that started on the clinical front line and moved to a digital platform.
Chairman
Dr Hsing-Hua Lai
Dr Lai pursues precision-medicine breakthroughs in implantation-window intervention and reproductive immunology, and has taken a forward-looking view in combining reproductive medicine with big-data analysis and advanced AI — working towards outcomes that are true, good and complete for every patient. That sense of purpose led him to found BiOLOVE, driving a comprehensive upgrade of the industry and building the company into an integrator of digital healthcare platforms with a global outlook.
Current and past roles
- Current: Chairman, BiOLOVE Biotechnology; Director, Stork Fertility Center
- Former: CEO, BiOLOVE Biotechnology
Professional background
- Research fellow, Division of Infertility and Reproductive Endocrinology, Taipei Veterans General Hospital
- Advanced training in reproductive technology, National University of Singapore
- Research fellow, IVF laboratory, Mackay Memorial Hospital, Taipei
- Director, Department of Obstetrics and Gynecology and Reproductive Medicine Center, Nanmen Hospital, Hsinchu
General Manager
Chao-Chin Liu
In reproductive medicine since 1993, with roles at Serono and Merck. As head of the reproductive medicine business unit at Merck Taiwan he grew the unit by 368%. He joined BiOLOVE in September 2023 to lead overseas business, and became General Manager in June 2025, driving digital transformation and global expansion with the HiSA platform at the centre.
Current and past roles
- Current: General Manager, BiOLOVE Biotechnology
- Former: Special Assistant to the Chairman and VP of Overseas Business, BiOLOVE Biotechnology
- Former: Head of the reproductive medicine business unit, Merck Taiwan
- Former: Serono Taiwan (from 1993; merged into Merck in 2007)
The professional team
At BiOLOVE, more than 20 software engineers work alongside five laboratory researchers. Code and data on one side, cells and research on the other. We believe only a genuine conversation between technology and medicine produces a system that is both precise and humane — and that conversation is where the intelligence in HiSA began.